Micronoma is the first cancer-detection company using liquid biopsy technology to detect and predict cancer by interrogating the microbial signal with clinical-grade accuracy at an early stage of the disease. Micronoma was founded by leaders in microbiome research, and committed to improving the lives of all involved in cancer diagnosis. The company started in 2019 and is headquartered in San Diego, California.

Biotechnology

Micronoma

Greg Sepich-Poore

Todd Czerwinski

The leadership team at Micronoma has experience in managing laboratory operations for various companies in the healthcare industry. They have a background in microbiology and Murine Leukemia Viruses from California State Polytechnic University-Pomona.

Leadership Team

About